Breaking India’s Education Minister Resigns Amidst ‘Cockroach Movement’ Pressure Indian Youth Lead Protests, Leading to Education Minister’s Resignation Egypt’s Heat Preparedness Questioned Amidst Rising Temperatures Aging Pop Icons Cher, Parton, Streisand, and Warwick Offer Blueprint for ‘Life Well-Lived’ New Tariffs Imposed by Former President Trump Spark Economic Debate

Saturday July 25, 2026

Reporter

Nuvectis Pharma, Inc.

2Articles Published

5Communities Covered

Published Articles

Press Release

Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23

Press Release

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23